Cullinan Therapeutics, Inc.
CGEM
$20.34
$0.703.56%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 334.54M | 351.89M | 377.90M | 332.60M | 265.48M |
| Total Receivables | 2.38M | 2.90M | 2.83M | -- | -- |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 5.06M | 6.62M | 6.03M | 9.64M | 10.43M |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | 341.97M | 361.41M | 386.76M | 342.24M | 275.91M |
|
|
|||||
| Total Current Assets | 341.97M | 361.41M | 386.76M | 342.24M | 275.91M |
| Net Property, Plant & Equipment | 2.50M | 2.78M | 3.05M | 1.54M | 1.75M |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 297.00K | 297.00K | 297.00K | 361.00K | 367.00K |
| Total Assets | 363.79M | 402.98M | 448.37M | 484.13M | 520.33M |
|
|
|||||
| Total Accounts Payable | 3.73M | 2.51M | 841.00K | 1.72M | 2.46M |
| Total Accrued Expenses | 34.71M | 30.57M | 35.12M | 28.33M | 21.97M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 666.00K | 725.00K | 780.00K | 1.19M | 1.39M |
| Total Finance Division Other Current Liabilities | 1.53M | 1.35M | 996.00K | 1.52M | 2.23M |
| Total Other Current Liabilities | 1.53M | 1.35M | 996.00K | 1.52M | 2.23M |
| Total Current Liabilities | 40.63M | 35.15M | 37.74M | 32.76M | 28.06M |
|
|
|||||
| Total Current Liabilities | 40.63M | 35.15M | 37.74M | 32.76M | 28.06M |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 1.41M | 1.66M | 1.90M | -- | 125.00K |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | 42.03M | 36.81M | 39.64M | 32.76M | 28.18M |
|
|
|||||
| Common Stock & APIC | 1.01B | 1.00B | 995.83M | 987.80M | 978.34M |
| Retained Earnings | -691.48M | -637.78M | -588.12M | -537.41M | -486.80M |
| Treasury Stock & Other | -134.00K | 127.00K | 1.02M | 973.00K | 607.00K |
| Total Common Equity | 321.75M | 366.17M | 408.73M | 451.37M | 492.15M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 321.75M | 366.17M | 408.73M | 451.37M | 492.15M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 321.75M | 366.17M | 408.73M | 451.37M | 492.15M |
|
|
|||||